ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrutinib in CLL
od
IMPACT Medicom
2022-12-13 16:00:00
Data wydania
14:34
Czas trwania
